Isolation of factor h from fraction i paste
AssigneesBaxter Healthcare S.A., Baxter International Inc.
InventorsShawn F. Bairstow, Sindhu Ramachandran, Richard Johnson, Nicholas J. Schill
Life of this patent
Estimating the term…
Loading patent…
AssigneesBaxter Healthcare S.A., Baxter International Inc.
InventorsShawn F. Bairstow, Sindhu Ramachandran, Richard Johnson, Nicholas J. Schill
Estimating the term…
Among other aspects, the present disclosure provides methods for preparing enriched compositions of plasma-derived Factor H from fractions formed during the manufacturing processes of established plasma-derived therapeutic compositions. Specifically, methods are provided for the isolation of Factor H from Fraction precipitates commonly discarded during the manufacture of commercial IgG therapeutics. Advantageously, the Factor H compositions prepared according to these methods have improved proteolytic profiles and reduced amidolytic activity.
A method for preparing an enriched Factor H composition from plasma, the method comprising the steps:
Dependencies are inferred from the claim text.